Clinical Trial Detail

NCT ID NCT02489357
Title Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

prostate cancer

Therapies

Degarelix

Pembrolizumab

Age Groups: adult

No variant requirements are available.